|
End-of-day quote
Shanghai S.E.
24/09/2026
|
5-day change | 1st Jan Change | ||
| 36.48 CNY | -0.27% |
|
+1.62% | -14.27% |
| Market Cap | 11.61B 1.73B 1.52B 1.43B 1.31B 2.45B 166B 2.47B 17.2B 6.67B 84.46B 6.49B 6.35B 275B | P/E 2024 |
11.3x | P/E 2025 | 14.6x |
|---|---|---|---|---|---|
| Enterprise Value | 9B 1.34B 1.18B 1.11B 1.01B 1.9B 129B 1.91B 13.34B 5.17B 65.49B 5.03B 4.92B 213B | EV / Sales 2024 |
3.4x | EV / Sales 2025 | 3.72x |
| Free-Float |
39.36% | Yield 2024 |
5.3% | Yield 2025 | 4.13% |
| 1 day | -0.27% | ||
| 1 week | +1.62% | ||
| Current month | -4.98% | ||
| 1 month | -6.44% | ||
| 3 months | -3.62% | ||
| 6 months | -7.51% | ||
| Current year | -14.27% |
| 1 week | 35.85 |  | 37.47 |
| 1 month | 35.46 | | 39.78 |
| Current year | 34.8 | | 46 |
| 1 year | 34.8 | | 49.94 |
| 3 years | 26.95 | | 57.98 |
| 5 years | 22.73 | | 57.98 |
| 10 years | 13.54 | | 140.05 |
| Manager | Title | Age | Since |
|---|---|---|---|
Yuan Dong Guo
CEO | Chief Executive Officer | 56 | 20/11/2014 |
Jun Chen
DFI | Director of Finance/CFO | 48 | 25/10/2019 |
Li Li Wen
IRC | Investor Relations Contact | 46 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Da Bin Chen
CHM | Chairman | 70 | 08/01/2015 |
Yu Cheng Zhou
BRD | Director/Board Member | 44 | 08/01/2015 |
Yuan Dong Guo
BRD | Director/Board Member | 56 | 08/01/2015 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.27% | +1.62% | -23.20% | -5.45% | 1.74B | |
| +2.68% | +3.87% | +58.22% | +114.68% | 1,026B | |
| +0.56% | +1.27% | +53.29% | +68.65% | 649B | |
| +0.02% | +0.99% | +19.10% | +73.58% | 468B | |
| +0.06% | +0.25% | +37.03% | +45.71% | 352B | |
| +1.16% | +4.10% | +21.99% | +29.39% | 271B | |
| -0.24% | +2.18% | +10.14% | +12.26% | 256B | |
| -0.01% | +7.89% | +41.57% | +51.68% | 220B | |
| -1.11% | +1.36% | +30.85% | +99.56% | 188B | |
| +0.30% | -7.19% | -32.43% | -60.56% | 170B | |
| Average | +0.44% | +1.22% | +21.66% | +42.95% | 360.08B | |
| Weighted average by Cap. | +1.14% | +1.25% | +37.27% | +67.64% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 2.81B 418M 368M 346M 316M 591M 40.11B 596M 4.16B 1.61B 20.41B 1.57B 1.53B 66.43B | 2.98B 444M 390M 368M 336M 628M 42.61B 633M 4.42B 1.71B 21.69B 1.67B 1.63B 70.57B |
| Net income | 1.05B 157M 138M 130M 118M 221M 15.02B 223M 1.56B 604M 7.65B 588M 575M 24.88B | 938M 140M 123M 116M 106M 198M 13.4B 199M 1.39B 538M 6.82B 524M 513M 22.2B |
| Net Debt | -2.35B -350M -308M -290M -265M -495M -33.61B -499M -3.48B -1.35B -17.1B -1.31B -1.29B -55.66B | -2.61B -388M -342M -322M -294M -550M -37.28B -554M -3.86B -1.5B -18.98B -1.46B -1.43B -61.75B |
Employees
671
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 24/09/26 | CN¥36.48 | -0.27% | 3,519,200 |
| 23/09/26 | CN¥36.58 | +0.44% | 1,808,030 |
| 22/09/26 | CN¥36.42 | -0.95% | 2,258,392 |
| 21/09/26 | CN¥36.77 | +1.72% | 2,444,408 |
| 18/09/26 | CN¥36.15 | +1.06% | 1,612,736 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 600211 Stock
Select your edition
All financial news and data tailored to specific country editions
